| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |